Back

Improving outcomes in HFpEF with GLP-1 receptor agonist

29 August 2026 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Disease of the thick heart: case-based discussion Cardiac Hypertrophy Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Brave new world of precision diagnosis and therapies
Doctor M. Desai (Cleveland, US)
Slides Video
Presentation thumbnail
Phenotypic convergence or causal cascade: stenosis, disarray, and infiltration
Professor W. Jaber (Cleveland, US)
Slides Video
Presentation thumbnail
The enzyme enigma
Doctor S. Keen (Cleveland, US)
Slides Video
Presentation thumbnail
Disease of the thick heart - panel discussion

Access the full session

Session thumbnail
Disease of the thick heart: case-based discussion
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:20 CET
You may be interested in
thumbnail
Congress Session
GLP-1RAs in obesity-related HFpEF: a new era in treatment
31 August 2025
thumbnail
Congress Presentation
In the clinic: obesity-related HFpEF.
22 May 2022
thumbnail
Congress Presentation
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
30 August 2025
thumbnail
Congress Session
The obesity phenotype of HFpEF: new therapies on our door step?
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources